Clinical Trials
3 trialsNCT01593241 2025-02-13
Therapy De-escalation in Seminoma Stage IIA/B
Swiss Cancer Institute
Phase 2 Terminated
NCT01055067 2021-04-06
ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors
Daiichi Sankyo
Phase 2 Terminated
NCT00042952 2013-01-17
Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer
National Cancer Institute (NCI)
Phase 2 Terminated